Recall: D-0133-2025

Class II - Potentially Harmful

Class IIClassification
2024-11-19Initiated
OngoingStatus
Mylan Institutional, Inc.Firm

Product

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20

Reason

Subpotent and Superpotent Drug

Distribution

Nationwide in the USA.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.